In silico Study of the interaction of fucoidan with thrombolytic agents
Tissue plasminogen activator (tPA) is one of the most widely used drugs in thrombolytic therapy. However, due to the inactivation of tPA in the bloodstream and increased risk of bleeding with increasing tPA dosages, the development of targeted delivery systems of tPA is required. For these purposes,...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Статья |
| 言語: | English |
| 出版事項: |
Wolters Kluwer Medknow Publications
2022
|
| 主題: | |
| オンライン･アクセス: | https://dspace.ncfu.ru/handle/20.500.12258/21888 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|